Invention Grant
US08217038B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
失效
用于治疗代谢紊乱，包括肥胖和糖尿病的大麻素受体拮抗剂/反向激动剂
- Patent Title: Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
- Patent Title (中): 用于治疗代谢紊乱，包括肥胖和糖尿病的大麻素受体拮抗剂/反向激动剂
-
Application No.: US12900252Application Date: 2010-10-07
-
Publication No.: US08217038B2Publication Date: 2012-07-10
- Inventor: John F. McElroy , Robert J. Chorvat
- Applicant: John F. McElroy , Robert J. Chorvat
- Applicant Address: US PA West Chester
- Assignee: Jenrin Discovery, Inc.
- Current Assignee: Jenrin Discovery, Inc.
- Current Assignee Address: US PA West Chester
- Agency: Vance Intellectual Property, PC
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/454 ; A61K31/41 ; A61K31/4155 ; A61K31/415 ; C07D413/02 ; C07D401/02 ; C07D257/02 ; C07D231/06
Abstract:
The present invention provides novel pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.
Public/Granted literature
Information query
IPC分类:
